Resources

Continuing Pharmacy Education

Pharmacy in Downers Grove


Chicago College of Pharmacy (CCP) offers a variety of resources and continuing pharmacy education programs throughout the year.


Mission

The Chicago College of Pharmacy is committed to the lifelong learning of its alumni, preceptors, and other interested pharmacists in various practice settings. The College provides high quality knowledge and application-based educational activities that enhance contemporary pharmacy practice.

Goal

To provide high quality continuing pharmacy education and professional development activities, which are applicable to contemporary pharmacy practice and meet the educational needs of pharmacists in various settings.

Our continuing pharmacy education activities will enable pharmacists to:

  1. improve their knowledge of contemporary pharmacy practice
  2. improve their ability to apply new knowledge to enhance patient care
  3. meet educational requirements for relicensure

Accreditation

Midwestern University Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 


Registration is now open!

Saturday June 3, 2017
6th Annual Updates in Diabetes and Related Chronic Care Topics

A daylong educational conference focused on different topics about diabetes intended for preceptors, alumni and other interested pharmacists.

Up to 7 contact hours of live ACPE accredited continuing pharmacy education will be available. Registrants may participate in up to four knowledge-based CPE activities, including the keynote address and two application-based, workshop style CPE activities. There will also introductory and advanced tracks of programming. Participants will be able to select which track they would like to participate in or can mix and match sessions from different tracks! A detailed agenda can be found below or in the registration link

Conference Goals:

  1. To educate participants with the most current evidence-based information about the prevention and treatment of diabetes and its related conditions
  2. To instill in participants a sense of responsibility and confidence to teach diabetes self-management and promote medication adherence and other healthy habits to patients
  3. To enhance the skills of participants including their ability to apply patient-specific information to therapeutic decisions and their ability to calculate insulin dosing regimens

Date/Time:
Saturday June 3, 2017
7:30 AM - 8:00 AM Check in and continental breakfast
The conference ends at 4:15 PM

Location:
Midwestern University
555 31st Street
Downers Grove, IL 60515
Click here for directions to campus and a campus map. 

Registration Fees:

To Register:

Register online by clicking here. The last day to register is Friday May 26, 2017.

Registration is limited to 100 individuals on a first come, first served basis.

Please contact Ms. Cheryl Elder at celder@midwestern.edu or 630.971.6417 with any questions regarding registration.

Other important information regarding NABP e-profile IDs:
Accredited providers of continuing pharmacy education must submit NABP e-profile IDs for participants who attend their CE programs. If you have not already obtained your NABP e-profile ID, please do so by visiting https://store.nabp.net/OA_HTML/xxnabpibeGblLogin.jsp  and following the steps. You will be asked for your NABP e-profile ID upon registering for this program.

 

Detailed Agenda

7:30 - 8:00AM
Registration/Continental Breakfast

8:00 - 8:05AM
Welcome

8:05 - 9:05AM
The Gut Microbiota in Obesity and Diabetes: Pathological and Treatment Implications
Speaker: Dr. Christian Evans
0074-0000-17-015-L01-P (knowledge-based CE activity)
1.0 contact hour of continuing pharmacy education (CPE)
1.    Describe the role of the following factors in the development of obesity and diabetes: Diet and exercise; the gut microbiota; antibiotics; pre and probiotics; and fecal microbiota transplant.
2.    Describe how these factors interact in the development of obesity and diabetes.
3.    Describe how these factors may be used in the prevention and management of obesity and diabetes.

9:10 - 10:10AM
Concurrent Session #1a
Your P.O. Plan: Picking an Oral Agent After Metformin in the Treatment of Diabetes (Introductory Track)
Speaker: Dr. Christie Schumacher
0074-0000-17-016-L01-P (knowledge-based CE activity)
1.0 contact hour of continuing pharmacy education (CPE)
1.    List the mechanism of action, relative safety and efficacy, and place in therapy for each of the main classes of non-insulin antidiabetic medications. 2.    Given a patient case, identify which class of non-insulin antidiabetic medications may be an appropriate choice of treatment.
3.    Recognize what pharmacists should educate patients about regarding proper disposal of non-insulin antidiabetic medications.

Concurrent Session #1b
Transitions of Care from Pediatrics to Young Adults (Advanced Track)
Speaker: Ms. Amy Fischl
0074-0000-17-017-L01-P (knowledge-based CE activity)
1.0 contact hour of continuing pharmacy education (CPE)
1.    Describe current guidelines for transitional care in young adults with diabetes.
2.    Discuss the role of the healthcare team approach in meeting goals for successful transitional care.
3.    List key resources for transitional care.

10:10 - 10:20AM
Break

10:20 - 11:50AM
Concurrent Session #2a

Everything but the Insulin: Non-insulin Medications in the Treatment of Patients with Diabetes (Introductory Track)
Speakers: Drs. Kristin Bradley, Elizabeth Van Dril and Christie Schumacher
0074-0000-17-018-L01-P (application-based CE activity)
1.5 contact hours of continuing pharmacy education (CPE)
1.    Given patient information, design an appropriate treatment and monitoring plan using non-insulin antidiabetic medications.
2.    Modify a patient's non-insulin antidiabetic medication treatment or monitoring plan based on new information.
3.    Write a counseling point for a patient regarding the proper disposal of non-insulin antidiabetic medications.  

Concurrent Session #2b
The Ups and Downs of Blood Glucose: A Look at Insulin Variability with Newer Agents (Advanced Track)
Speakers: Drs. Marisa Censi and Sue Cornell
0074-0000-17-019-L01-P (application-based CE activity)
1.5 contact hours of continuing pharmacy education (CPE)
1.    Discuss advances and implications for the use of glucagon-like peptide-1 (GLP-1) receptor agonist and insulin therapy in the diabetes management and care plan.
2.    Compare the pharmacokinetic, pharmacodynamics, and variability parameters of various insulin formulations and delivery methods.
3.    Given a case of a patient with Type 2 diabetes, design a pharmacotherapy plan that includes medications discussed.  

11:55AM - 12:25PM
2017 Highlights in Diabetes Management
Speaker: Dr. Jennifer D'Souza
0074-0000-17-020-L01-P (knowledge-based CE activity)
0.5 contact hour of continuing pharmacy education (CPE) 
1.    Summarize changes to recent national guidelines for the care of patients with diabetes.
2.    Identify current and emerging pharmacotherapy treatments, guidelines, and patient goals for patients with diabetes.

12:25 - 1:00PM
Lunch

1:00 - 2:30PM
Concurrent Session #3a
On Pens and Needles: Insulin Products in the Treatment of Patients with Diabetes (Introductory Track)
Speakers: Drs. Lea dela Pena and Jennifer D'Souza
0074-0000-17-021-L01-P (application-based CE activity)
1.5  contact hours of continuing pharmacy education (CPE)  
1.    Identify various pen devices used in the treatment of diabetes.
2.    Explain how to prepare each device for use.
3.    Demonstrate appropriate use of each product.
4.    Recognize the expiration dates for each product.
5.    Write a counseling point for a patient regarding the proper storage and disposal of insulin products. 

Concurrent Session #3b
Don't Miss a Beat: An Update on the Cardiovascular Outcomes Trials (CVOTs) for Newer Antihyperglycemic Agents (Advanced Track) Speakers: Drs. Kristin Bradley, Elizabeth Van Dril and Christie Schumacher
0074-0000-17-022-L01-P (application-based CE activity)
1.5  contact hours of continuing pharmacy education (CPE)  
1.    Describe the Food and Drug Administration's rationale for mandating that cardiovascular outcomes trials be conducted on new antidiabetic therapies.
2.    Discuss the clinical impact of the results of recently published cardiovascular outcomes trials for DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors.
3.    Identify the limitations associated with recently published cardiovascular outcomes trials for DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors.

2:30 - 2:40PM
Break

2:40 - 3:40PM
Keynote Address:
The World of a Proactive Pharmacist in Diabetes Care
Keynote Speaker: Dr. Jessica Kerr
0074-0000-17-023-L01-P (knowledge-based CE activity)
1.0 contact hour of continuing pharmacy education (CPE)
1.    Compare and contrast diabetes care outcomes in a health care team utilizing pharmacy specialists.
2.    Identify pharmacy/pharmacist roles for progressive diabetes care management.
3.    Discuss areas of opportunity to serve as patient educators and advocates for diabetes management.

3:45 - 4:15PM
Questions Answered: Ask the Experts!
Speakers: Drs. Sue Cornell, Jessica Kerr and Christie Schumacher
0074-0000-17-024-L01-P (knowledge-based CE activity)
0.5 contact hour of continuing pharmacy education (CPE)
1.    List at least 3 take home points regarding diabetes management or education.
2.    Identify at least 2 topics regarding diabetes management or education for future self-study. 

4:15PM
Closing Remarks/Submission of Evaluations

For information on CCP continuing pharmacy education programs, please contact:
Jacob P. Gettig, Pharm.D., MPH, BCPS, CHCP
Associate Dean for Postgraduate Education
Chicago College of Pharmacy
Midwestern University
555 31st Street
Downers Grove, IL 60515
630/515-7324
jgetti@midwestern.edu